A Single-Center Pharmacoeconomic Pilot Study of BOTOX (Botulinum Toxin Type A) for the Prophylactic Treatment of Migraine Headaches.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 12 Jul 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 26 Feb 2009 New trial record